A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
University of Chicago
AstraZeneca
University of California, San Francisco
Johns Hopkins University
Stanford University
Johns Hopkins University
Fred Hutchinson Cancer Center
Samsung Medical Center